Psychiatric Drugs: Antipsychotics & Antidepressants (MRCP Part 1)
- Crack Medicine

- Jan 21
- 4 min read
TL;DR:
In MRCP Part 1, psychiatric drugs are tested through classic side-effects, mechanism-based reasoning, and dangerous interactions rather than exhaustive drug lists. Focus on dopamine blockade effects, serotonin toxicity, QT prolongation, and overdose patterns. This article covers the exact examinable scope, high-yield facts, a mini-MCQ, common traps, and a practical revision checklist.
Why this topic matters in MRCP Part 1
Psychiatric pharmacology is a high-yield, high-predictability area in MRCP Part 1. Questions are rarely obscure; instead, they test whether you can connect basic pharmacology to recognisable clinical syndromes—for example, linking dopamine blockade to extrapyramidal side effects or tricyclic antidepressants to arrhythmias in overdose.
Another reason this topic scores well is that examiners frequently reuse the same drug–effect patterns across multiple questions. Candidates who understand mechanisms consistently outperform those who memorise isolated facts.
If you are planning your revision, this topic integrates well with the broader MRCP Part 1 exam structure and pairs naturally with cardiovascular pharmacology and autonomic nervous system questions.
Scope of psychiatric drugs for MRCP Part 1
At MRCP Part 1 level, you are expected to know:
Major classes of antipsychotics and antidepressants
Mechanism → adverse effect → contraindication relationships
High-risk drug interactions (QT prolongation, serotonin syndrome)
Key features of toxicity and overdose
You are not expected to know:
Detailed dose titration schedules
Complex treatment algorithms
Rare or specialist-only drugs
Authoritative references such as the British National Formulary and NICE
Clinical Knowledge Summaries form the knowledge base for exam questions.

The 5 most tested subtopics
1. Typical vs atypical antipsychotics
This is the cornerstone of antipsychotic questions.
Typical antipsychotics (e.g. haloperidol)
Strong D2 blockade
Higher risk of extrapyramidal side effects (EPSEs)
Hyperprolactinaemia is common
Atypical antipsychotics (e.g. olanzapine, quetiapine)
Lower EPSE risk
Higher metabolic risk (weight gain, diabetes, dyslipidaemia)
Exam pearl: Risperidone behaves more like a typical antipsychotic for prolactin elevation.
2. Extrapyramidal side effects (EPSEs)
Examiners often test timing, not just symptoms.
Syndrome | Onset | Key feature |
Acute dystonia | Hours–days | Painful muscle spasms |
Akathisia | Days–weeks | Inner restlessness |
Parkinsonism | Weeks | Tremor, rigidity |
Tardive dyskinesia | Months–years | Choreoathetoid movements |
Management principles are usually implied rather than explicitly asked.
3. Antidepressant classes & toxicology
Antidepressants are frequently examined via side-effect profiles and overdose risk.
SSRIs:
GI upset, sexual dysfunction
Hyponatraemia (SIADH), especially in older adults
TCAs:
Anticholinergic effects
Sodium channel blockade → arrhythmias in overdose
MAOIs:
Hypertensive crisis with tyramine-containing foods
4. Serotonin syndrome
A classic MRCP Part 1 vignette.
Features include:
Autonomic instability
Hyperreflexia and clonus
Recent drug interaction (e.g. SSRI + MAOI, tramadol, linezolid)
Key distinction: Serotonin syndrome causes hyperreflexia, unlike neuroleptic malignant syndrome.
5. QT prolongation and cardiac risk
Several psychiatric drugs prolong the QT interval. Exam questions often involve:
Baseline cardiac disease
Combination with other QT-prolonging drugs
Collapse or syncope scenarios
This topic overlaps strongly with ECG interpretation.
High-yield facts you should memorise
Dopamine blockade in the tuberoinfundibular pathway causes hyperprolactinaemia
Clozapine is associated with agranulocytosis and myocarditis
TCAs block cardiac sodium channels
SSRIs can precipitate SIADH
Akathisia is often mistaken for anxiety
Serotonin syndrome presents with clonus and hyperreflexia
Atypical antipsychotics increase metabolic syndrome risk
MAOIs interact dangerously with sympathomimetics
Antipsychotics vs antidepressants: exam comparison
Feature | Antipsychotics | Antidepressants |
Main mechanism | Dopamine D2 blockade | Serotonin ± noradrenaline modulation |
Common exam risk | EPSEs, metabolic effects | Overdose toxicity |
Cardiac issue | QT prolongation | QT (TCAs, citalopram) |
Overdose danger | Variable | High with TCAs |
Mini-MCQ (exam style)
A 30-year-old man develops neck stiffness and upward deviation of the eyes 24 hours after starting haloperidol. He is afebrile and anxious. What is the most likely diagnosis?
Answer: Acute dystonia
Explanation: This is an extrapyramidal side effect due to acute dopamine blockade. The rapid onset differentiates it from tardive dyskinesia and neuroleptic malignant syndrome.
Practising similar questions in a high-quality MRCP question bank reinforces these patterns.
Common mistakes candidates make
Confusing akathisia with worsening psychosis
Forgetting TCAs are dangerous in overdose
Missing QT prolongation in combined drug regimens
Mixing up serotonin syndrome and NMS
Memorising drug names instead of class effects
Practical revision checklist
Learn drug classes before individual agents
Create a one-page EPSE timeline
Revise ECG basics alongside psychiatric drugs
Use mixed-topic MCQs rather than isolated reading
Revisit psychiatry close to the exam—it is high-retention
Structured teaching resources, such as focused MRCP lectures, can help consolidate these topics efficiently.
FAQs
Do I need to memorise all psychiatric drugs for MRCP Part 1?
No. Focus on major classes, flagship drugs, and predictable adverse-effect patterns.
Are antidepressant doses tested?
Rarely. Toxicity, interactions, and mechanisms are far more important.
How often is serotonin syndrome tested?
Very frequently. It is a classic interaction-based vignette.
Are MAOIs still relevant for MRCP?
Yes, mainly for their dangerous food and drug interactions.
Ready to start?
To maximise marks in psychiatric pharmacology, integrate this guide with the official MRCP Part 1 syllabus and reinforce learning using high-quality MCQs and structured revision courses. Consistent pattern recognition—not rote memorisation—is what converts knowledge into exam success.
Sources
British National Formulary (BNF): https://bnf.nice.org.uk/
NICE Clinical Knowledge Summaries (Depression & Psychosis):https://cks.nice.org.uk/topics/depression/https://cks.nice.org.uk/topics/psychosis-schizophrenia/



Comments